AJR 62: Relative to prescription drug costs

7 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with

and connect to

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of AJR 62: Relative to prescription drug costs

Sebastian Ridley-Thomas	Sponsors	Sebastian Ridley-Thomas sponsored AJR 62: Relative to prescription drug costs.	None
California Public Interest Research Group, Inc.	Lobbied on it	California Public Interest Research Group, Inc. named AJR 62: Relative to prescription drug costs in 3 lobbying reports.	3 reports
GSK	Lobbied on it	GSK named AJR 62: Relative to prescription drug costs in 3 lobbying reports.	3 reports
Amgen	Lobbied on it	Amgen named AJR 62: Relative to prescription drug costs in 2 lobbying reports.	2 reports
California Life Sciences	Lobbied on it	California Life Sciences named AJR 62: Relative to prescription drug costs in 1 lobbying report.	1 report
Merck, Sharp & Dohme LLC	Lobbied on it	Merck, Sharp & Dohme LLC named AJR 62: Relative to prescription drug costs in 1 lobbying report.	1 report
Relative to prescription drug costs.	Source records	AJR 62: Relative to prescription drug costs has an explicit source reference to Relative to prescription drug costs..	None

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…